Amphastar Pharmaceuticals (FRA:29A) Ending Cash Position : €145.0 Mil (As of Dec. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Amphastar Pharmaceuticals Ending Cash Position?

Amphastar Pharmaceuticals's Ending Cash Position for the quarter that ended in Dec. 2024 was €145.0 Mil.

Amphastar Pharmaceuticals's quarterly Ending Cash Position declined from Jun. 2024 (€176.4 Mil) to Sep. 2024 (€173.3 Mil) and declined from Sep. 2024 (€173.3 Mil) to Dec. 2024 (€145.0 Mil).

Amphastar Pharmaceuticals's annual Ending Cash Position declined from Dec. 2022 (€147.6 Mil) to Dec. 2023 (€132.5 Mil) but then increased from Dec. 2023 (€132.5 Mil) to Dec. 2024 (€145.0 Mil).

Amphastar Pharmaceuticals Ending Cash Position Historical Data

The historical data trend for Amphastar Pharmaceuticals's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amphastar Pharmaceuticals Ending Cash Position Chart

Amphastar Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

77.69

112.03

147.58

132.54

145.01

Amphastar Pharmaceuticals Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Ending Cash Position	Get a 7-Day Free Trial															132.54	185.27	176.37	173.31	145.01

Amphastar Pharmaceuticals Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Amphastar Pharmaceuticals's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	138.026	+	6.985
	=	145.0

Amphastar Pharmaceuticals's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	183.695	+	-38.684
	=	145.0

Amphastar Pharmaceuticals Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Amphastar Pharmaceuticals's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Amphastar Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amphastar Pharmaceuticals Inc (FRA:29A) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

AMPH:USA

Address

11570 6th Street, Rancho Cucamonga, CA, USA, 91730

Website

https://www.amphastar.com

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Amphastar Pharmaceuticals Headlines

No Headlines